18:51 IST
NSE
Other Announcement
Orchid Pharma Other Announcement
Orchid Pharma filed its Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI regulations regarding its prior QIP issue.
Orchid Pharma Ltd
- Share price
- ₹1,024.25
- Market cap
- ₹6,134 Cr
- Revenue (annual)
- ₹811.3 Cr
- Net profit (annual)
- ₹20.55 Cr
- P/E (TTM)
- 707.7×Sector 47.4×
- Promoter holding
- 74.45%+4.61% QoQ
- FII holding
- 0.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Financial Results 4Other Announcement 3Board Meeting Date 3Merger & Restructuring 2Management Change 2Legal & Regulatory 2Acquisition 2New Order Win 1Fund Raise 1Capital Structure Change 1Board Meeting Outcome 1Annual Report 1Annual General Meeting 1
Time
3 announcements with these filters
19:05 IST
BSE
Other Announcement
Orchid Pharma Other Announcement
Orchid Pharma Ltd has filed its quarterly shareholding pattern as of June 30, 2026, disclosing the promoter and public shareholding distribution.
14:46 IST
BSE
Other Announcement
Orchid Pharma Other Announcement
Orchid Pharma Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report details statutory compliance status and historical observations.